Rhumbline Advisers Elanco Animal Health Inc Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Rhumbline Advisers holds 481,438 shares of ELAN stock, worth $5.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
481,438
Previous 479,229
0.46%
Holding current value
$5.21 Million
Previous $7.04 Million
17.13%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding ELAN
# of Institutions
439Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$901 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$554 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$528 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$252 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$221 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.13B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...